Literature DB >> 23023070

A sensitive liquid chromatography-mass spectrometry method for simultaneous determination of three diterpenoid esters from Euphorbia lathyris L. in rat plasma.

Xia Meng1, Xu Zhao, Zhimin Long, Yang Yuan, Hefei Zhuang, Kaishun Bi, Xiaohui Chen.   

Abstract

A selective and sensitive liquid chromatography-mass spectrometry (LC-MS) method was developed for the simultaneous determination of Euphorbia factor L(1), Euphorbia factor L(2) and Euphorbia factor L(3) from Euphorbiae semen in rat plasma. Larotaxel was added to a 200 μL plasma sample as the internal standard (IS). The plasma sample was extracted by 2 mL ether and separated on an Elite C(18) column (150 mm × 4.6 mm, 5 μm) with the mobile phase of methanol-water performing gradient elution within 11.0 min. All the three analytes were detected in the selected ion monitoring (SIM) mode with positive electrospray ionization. The calibration curves were linear in the range of 2.0-200 ng/mL and the lower limits of quantification (LLOQ) were 2.0 ng/mL for all the three analytes. The intra-day and inter-day precisions were all within 8.6% and 14.6% for the three analytes, while the accuracy was less than 9.7% and 7.5%, respectively. The validated method was firstly and successfully applied to the pharmacokinetic study of Euphorbia factor L(1), Euphorbia factor L(2) and Euphorbia factor L(3) from Euphorbiae semen after oral administration in rat plasma.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23023070     DOI: 10.1016/j.jpba.2012.09.005

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  1 in total

1.  Comparison of Pharmacokinetics and Tissue Distribution Characteristics of Three Diterpenoid Esters in Crude and Prepared Semen Euphorbiae.

Authors:  Hui-Nan Wang; Pei-Hua Wang; Zi-Ye Yang; Gui-Mei Zhang; Meng-Yu Chen; Ming-Rui Jiang; Zhu-Zhu Yue; Zhi-Cheng Wang; Jing-Qiu Zhang; Yan-Hua Cao; Hong An; Ying-Zi Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-16       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.